文献速递心脑血管急症

ESC 0/1小时高敏肌钙蛋白I算法在疑似NSTEMI患者正常与异常心电图中的表现

Performance of the ESC 0/1 h hs-cTnI algorithm in suspected NSTEMI patients with normal versus abnormal electrocardiograms.
PubMed 文献 · Am J Emerg Med · 2026-01-19
一句话结论ESC 0/1-h hs-cTnI算法在所有心电图表现中排除安全性优异,但缺血性心电图改变者特异性较低、假阳性排除风险较高。

该回顾性分析纳入1535例疑似急性冠脉综合征的急诊患者,按初始心电图分为正常组(n=888)和异常组(n=647),异常组再分为缺血性(n=464)和非缺血性(n=183)。应用ESC 0/1-h hs-cTnI算法进行风险分层,评估诊断性能及30天和180天全因死亡与主要不良心血管事件的预后价值。异常心电图组敏感性和阴性预测值均为100%,正常组分别为98.8%和99.5%;缺血性心电图改变者特异性81.2%,显著低于正常组的91.6%(P<0.001)。算法在两组中均能有效分层死亡风险,但在异常心电图组对MACE的区分能力有限。

要点

  • 异常心电图组ESC 0/1-h hs-cTnI算法敏感性和阴性预测值均为100%,正常组分别为98.8%和99.5%。
  • 缺血性心电图改变者特异性81.2%,显著低于正常心电图组的91.6%(P<0.001),假阳性排除风险较高。
  • 正常心电图组亚组分析中,女性敏感性95.5%、疼痛发作≤3小时者97.9%、年龄≤65岁者98.1%,均略低。
  • 算法在两组中均能有效分层死亡风险,但在异常心电图组对MACE的区分能力有限。
  • 作者认为临床医生应结合缺血性心电图表现与临床病史解读算法结果,并对正常心电图中的女性、年轻患者和早期就诊者保持警惕。

适用人群与场景

  • 急诊科疑似非ST段抬高型心肌梗死(NSTEMI)患者,共1535例,按初始心电图分为正常组(n=888)和异常组(n=647),异常组再分为缺血性(n=464)和非缺血性(n=183)。

研究设计与关键结果

  • 研究类型为回顾性分析,纳入1535例疑似ACS患者,按初始心电图分组并应用ESC 0/1-h hs-cTnI算法进行风险分层,评估诊断性能及30天和180天全因死亡与MACE的预后价值。
  • 异常心电图组敏感性和阴性预测值均为100%,正常心电图组分别为98.8%和99.5%。
  • 缺血性心电图改变者特异性81.2%,显著低于正常心电图组的91.6%(P<0.001)。
  • 正常心电图组亚组分析显示敏感性略低:女性95.5%、疼痛发作≤3小时者97.9%、年龄≤65岁者98.1%。
  • 算法在两组中均能有效分层死亡风险,但在异常心电图组对MACE的区分能力有限。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • ESC 0/1-h hs-cTnI算法在所有心电图表现中排除安全性优异,可用于急诊疑似NSTEMI患者的排除评估。
  • 缺血性心电图改变者特异性较低(81.2% vs 正常组91.6%),假阳性排除风险较高,作者认为临床医生应结合缺血性心电图表现与临床病史解读算法结果。
  • 作者认为对正常心电图中的女性、年龄≤65岁患者和疼痛发作≤3小时就诊者需警惕潜在漏检。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the diagnostic and prognostic performance of the ESC 0/1-h high-sensitivity cardiac troponin I(hs-cTnI) algorithm in emergency department patients with suspected non-ST-segment elevation myocardial infarction(NSTEMI), stratified by by initial electrocardiogram (ECG) findings.

METHODS: This retrospective analysis included 1535 patients with suspected ACS. Based on initial ECG, patients were categorized into normal (n = 888) or abnormal (n = 647) groups,with the abnormal group further stratified into ischemic (n = 464) and non-ischemic (n = 183).The ESC 0/1 h hs-cTnI algorithm was applied for risk stratification. Diagnostic performance (sensitivity, specificity, NPV, PPV) was evaluated against clinical diagnosis. Prognostic value for 30-day and 180-day all-cause mortality and major adverse cardiovascular events (MACE) was assessed.

RESULTS: Sensitivity and NPV in the abnormal ECG group were both 100%, compared to 98.8% and 99.5% in the normal ECG group. Specificity was significantly lower in patients with ischemic ECG changes (81.2%) than in the normal ECG group (91.6%, P < 0.001). Subgroup analysis showed slightly lower sensitivity in women (95.5%), patients with pain onset ≤3 h (97.9%), and those aged ≤65 years (98.1%) within the normal ECG group. The algorithm effectively stratified mortality risk in both groups but showed limited discrimination for MACE in the abnormal ECG group.

CONCLUSION: The ESC 0/1-h hs-cTnI algorithm provides excellent rule-out safety across all ECG presentations. Crucially, a lower specificity-driven primarily by the ischemic ECG phenotype-suggests a higher risk of false-positive rule-in in this subgroup. Clinicians should integrate ischemic ECG patterns with clinical history to interpret algorithm results. Additionally, vigilance for potential under-detection in specific normal-ECG subgroups (women, younger patients, early presenters) remains warranted.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Feng ZQ, Xu F, Fu YN, et al. Performance of the ESC 0/1 h hs-cTnI algorithm in suspected NSTEMI patients with normal versus abnormal electrocardiograms. Am J Emerg Med. 2026. PMID: 41592427. doi:10.1016/j.ajem.2026.01.026

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。